Annual CFI
$71.01 M
+$165.10 M+175.47%
December 31, 2023
Summary
- As of February 8, 2025, VOR annual cash flow from investing activities is $71.01 million, with the most recent change of +$165.10 million (+175.47%) on December 31, 2023.
- During the last 3 years, VOR annual CFI has risen by +$75.17 million (+1806.51%).
- VOR annual CFI is now at all-time high.
Performance
VOR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$34.00 K
-$53.02 M-100.06%
September 30, 2024
Summary
- As of February 8, 2025, VOR quarterly cash flow from investing activities is -$34.00 thousand, with the most recent change of -$53.02 million (-100.06%) on September 30, 2024.
- Over the past year, VOR quarterly CFI has dropped by -$10.37 million (-100.33%).
- VOR quarterly CFI is now -100.06% below its all-time high of $52.99 million, reached on June 30, 2024.
Performance
VOR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$107.26 M
-$40.57 M-27.44%
September 30, 2024
Summary
- As of February 8, 2025, VOR TTM cash flow from investing activities is $107.26 million, with the most recent change of -$40.57 million (-27.44%) on September 30, 2024.
- Over the past year, VOR TTM CFI has increased by +$36.26 million (+51.06%).
- VOR TTM CFI is now -27.44% below its all-time high of $147.83 million, reached on June 30, 2024.
Performance
VOR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VOR Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +175.5% | -100.3% | +51.1% |
3 y3 years | +1806.5% | -100.3% | +51.1% |
5 y5 years | +100.0% | -100.3% | +51.1% |
VOR Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +175.5% | -100.1% | +100.0% | -27.4% | +210.0% |
5 y | 5-year | at high | +175.5% | -100.1% | +100.0% | -27.4% | +210.0% |
alltime | all time | at high | +175.5% | -100.1% | +100.0% | -27.4% | +210.0% |
Vor Biopharma Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$34.00 K(-100.1%) | $107.26 M(-27.4%) |
Jun 2024 | - | $52.99 M(+20.5%) | $147.83 M(+36.3%) |
Mar 2024 | - | $43.97 M(+325.5%) | $108.48 M(+52.8%) |
Dec 2023 | $71.01 M(-175.5%) | $10.34 M(-74.5%) | $71.01 M(-295.3%) |
Sep 2023 | - | $40.54 M(+197.2%) | -$36.36 M(-43.4%) |
Jun 2023 | - | $13.64 M(+109.9%) | -$64.20 M(-20.3%) |
Mar 2023 | - | $6.50 M(-106.7%) | -$80.54 M(-14.4%) |
Dec 2022 | -$94.09 M | -$97.04 M(-863.9%) | -$94.09 M(+3028.0%) |
Sep 2022 | - | $12.70 M(-570.1%) | -$3.01 M(-87.6%) |
Jun 2022 | - | -$2.70 M(-61.7%) | -$24.20 M(-75.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$7.05 M(+18.5%) | -$97.53 M(+6.4%) |
Dec 2021 | -$91.65 M(+2102.6%) | -$5.95 M(-29.8%) | -$91.65 M(+5.1%) |
Sep 2021 | - | -$8.49 M(-88.8%) | -$87.17 M(+8.6%) |
Jun 2021 | - | -$76.04 M(+6393.7%) | -$80.28 M(+1577.0%) |
Mar 2021 | - | -$1.17 M(-20.7%) | -$4.79 M(+15.0%) |
Dec 2020 | -$4.16 M(+456.3%) | -$1.48 M(-6.9%) | -$4.16 M(+55.0%) |
Sep 2020 | - | -$1.59 M(+187.5%) | -$2.68 M(+144.7%) |
Jun 2020 | - | -$552.00 K(+1.3%) | -$1.10 M(+101.3%) |
Mar 2020 | - | -$545.00 K | -$545.00 K |
Dec 2019 | -$748.00 K(<-9900.0%) | - | - |
Dec 2018 | $0.00 | - | - |
FAQ
- What is Vor Biopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Vor Biopharma?
- What is Vor Biopharma annual CFI year-on-year change?
- What is Vor Biopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Vor Biopharma?
- What is Vor Biopharma quarterly CFI year-on-year change?
- What is Vor Biopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Vor Biopharma?
- What is Vor Biopharma TTM CFI year-on-year change?
What is Vor Biopharma annual cash flow from investing activities?
The current annual CFI of VOR is $71.01 M
What is the all time high annual CFI for Vor Biopharma?
Vor Biopharma all-time high annual cash flow from investing activities is $71.01 M
What is Vor Biopharma annual CFI year-on-year change?
Over the past year, VOR annual cash flow from investing activities has changed by +$165.10 M (+175.47%)
What is Vor Biopharma quarterly cash flow from investing activities?
The current quarterly CFI of VOR is -$34.00 K
What is the all time high quarterly CFI for Vor Biopharma?
Vor Biopharma all-time high quarterly cash flow from investing activities is $52.99 M
What is Vor Biopharma quarterly CFI year-on-year change?
Over the past year, VOR quarterly cash flow from investing activities has changed by -$10.37 M (-100.33%)
What is Vor Biopharma TTM cash flow from investing activities?
The current TTM CFI of VOR is $107.26 M
What is the all time high TTM CFI for Vor Biopharma?
Vor Biopharma all-time high TTM cash flow from investing activities is $147.83 M
What is Vor Biopharma TTM CFI year-on-year change?
Over the past year, VOR TTM cash flow from investing activities has changed by +$36.26 M (+51.06%)